First Canadian Participant Dosed in ARGUS Trial, A Phase 2
PARAMUS, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- Epygenix Therapeutics, a clinical-stage biopharmaceutical company focused on genetically screening,...
United States Hong Kong United Kingdom Epygenix Therapeutics Inc Business Development Lorianne Masuoka
Source: globenewswire.com